BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 27041027)

  • 1. Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer.
    Teramoto S; Osada H; Sato Y; Shozu M
    Fertil Steril; 2016 Jul; 106(1):113-118. PubMed ID: 27041027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
    Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
    Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How many oocytes are optimal to achieve multiple live births with one stimulation cycle? The one-and-done approach.
    Vaughan DA; Leung A; Resetkova N; Ruthazer R; Penzias AS; Sakkas D; Alper MM
    Fertil Steril; 2017 Feb; 107(2):397-404.e3. PubMed ID: 27916206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis.
    Schwarze JE; Crosby JA; Zegers-Hochschild F
    Fertil Steril; 2016 Dec; 106(7):1714-1717.e1. PubMed ID: 27678033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval.
    Wirleitner B; Okhowat J; Vištejnová L; Králíčková M; Karlíková M; Vanderzwalmen P; Ectors F; Hradecký L; Schuff M; Murtinger M
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):118-125. PubMed ID: 29134715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dominant follicle status at the time of retrieval on the clinical outcomes in natural cycle IVF combined with immature oocyte treatment.
    Li JH; Sun TC; Zhang SW; Jiao TT; Cheng YB; Dong P; Chian RC; Xu Y
    Aging (Albany NY); 2022 Jun; 14(11):4728-4738. PubMed ID: 35674776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
    Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles.
    Baker VL; Brown MB; Luke B; Smith GW; Ireland JJ
    Fertil Steril; 2015 Nov; 104(5):1145-52.e1-5. PubMed ID: 26297646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue.
    Dueholm Hjorth IM; Kristensen SG; Dueholm M; Humaidan P
    Fertil Steril; 2020 Aug; 114(2):379-387. PubMed ID: 32624219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study.
    Chen YH; Xu XH; Wang Q; Zhang SD; Jiang LL; Zhang CL; Ge ZJ
    J Assist Reprod Genet; 2015 Oct; 32(10):1459-67. PubMed ID: 26384107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
    Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
    Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salpingectomy may decrease antral follicle count but not live birth rate for IVF-ET patients aged 35-39 years: a retrospective study.
    Chen T; Zhao F; Wang Q; Liu C; Lan Y; Wang S; Xin Z; Yang X
    J Ovarian Res; 2020 Jul; 13(1):80. PubMed ID: 32684158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose human chorionic gonadotropin alone can complete follicle maturity: successful application to modified natural cycle in vitro fertilization.
    Paulson RJ; Chung K; Quaas AM; Mucowski SJ; Jabara SI; Bendikson KA
    Fertil Steril; 2016 May; 105(5):1228-1231. PubMed ID: 26852420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.